HBW Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

In Brief: Renaissance Cosmetics

This article was originally published in The Rose Sheet

Executive Summary

Renaissance Cosmetics: Net sales rose 35.4% to $40.9 mil. for the fiscal 1997 first quarter (ended June 30), driven by sales from acquisitions completed after the first fiscal quarter of 1996, including the Procter & Gamble and MEM fragrances and the Nat Robbins color cosmetics, the company reported in its most recent 10-Q filing. Fragrance sales grew 53.1% to $16 mil. (39.2% of net sales), aided by net sales of $5.6 mil. from the MEM and P&G brands, the company said. Cosmetics revenues increased 24.8% to $14.7 mil. (35.9% of consolidated sales), boosted by Nat Robbins sales of $4 mil. and the introduction of Nail Fetish teen artificial nails and accessories, the company noted. International sales rose 27.6% to $10.2 mil., or 24.9% of overall sales. Renaissance reported a net loss of $4.4 mil., down slightly from last year's loss of $4.5 mil...
Advertisement
Advertisement
UsernamePublicRestriction

Register

RS004575

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel